177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Sichuan Enray Pharmaceutical Sciences Company
Arvinas Inc.
Eli Lilly and Company
Eli Lilly and Company
Turning Point Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
TransThera Sciences (Nanjing), Inc.
Hoffmann-La Roche
Alume Biosciences, Inc.
Xynomic Pharmaceuticals, Inc.
Salubris Biotherapeutics Inc
NantCell, Inc.
Turning Point Therapeutics, Inc.
TransThera Sciences (Nanjing), Inc.
Dana-Farber Cancer Institute
Seoul St. Mary's Hospital
Kineta Inc.
DualityBio Inc.
Institut Bergonié
Dana-Farber Cancer Institute
Genexine, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Jewish General Hospital
M.D. Anderson Cancer Center